| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |